Live from the NIH registry
Studies recruiting near Toledo right now
Top 25 of 208 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - Alexis — Toledo, Ohio (1.4 mi)
· Sponsor: R1 Therapeutics
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Mercy St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Synairgen Research Ltd.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Toledo Clinic Cancer Center — Toledo, Ohio (1.4 mi)
· Sponsor: Guardant Health, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Taylor Cancer Research Center ( Site 9500) — Maumee, Ohio (7.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis
Brain Stroke, Stenting Treatment
Phase 3
Interventional 342 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: ProMedica Health System
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Mercy Health - St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: PPD Development, LP
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Mercy Health - Perrysburg Hospital — Perrysburg, Ohio (7.7 mi)
· Sponsor: NRG Oncology
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Recurrent or Metastatic Solid Tumors
Phase 1
Interventional 76 participants sought
Research Site — Maumee, Ohio (7.9 mi)
· Sponsor: Daiichi Sankyo
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Toledo, Ohio (1.4 mi)
· Sponsor: Medtronic
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Toledo, Ohio (1.4 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
N/A
Observational 550 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Tempus AI
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
ProMedica — Toledo, Ohio (1.4 mi)
· Sponsor: Novo Nordisk A/S
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Saint Vincent Mercy Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Mercy Health — Toledo, Ohio (1.4 mi)
· Sponsor: Medical University of South Carolina
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: NRG Oncology
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
Cannabinoid Hyperemesis Syndrome
Phase 3
Interventional 114 participants sought
Mercy Saint Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Mercy Bon Secours Saint Vincent Medical Center